A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers

UnknownOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Head and Neck Cancer
Trial Locations (3)

77030

RECRUITING

University of Texas MD Anderson, Houston

02115

NOT_YET_RECRUITING

Harvard Medical School - Brigham and Women's Hospital, Boston

02215

RECRUITING

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

University of Southern California

OTHER

collaborator

University of Minnesota

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Brigham and Women's Hospital

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Amgen

INDUSTRY

collaborator

AstraZeneca

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Johnson & Johnson

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Pfizer

INDUSTRY

collaborator

Critical Path Institute - Predictive Safety Testing Consortium

UNKNOWN

lead

Foundation for the National Institutes of Health

OTHER